ZEB1-associated drug resistance in cancer cells is reversed by the class I HDAC inhibitor mocetinostat. (Q35695410)

From Wikidata
Jump to navigation Jump to search
scientific article published on 14 April 2015
edit
Language Label Description Also known as
English
ZEB1-associated drug resistance in cancer cells is reversed by the class I HDAC inhibitor mocetinostat.
scientific article published on 14 April 2015

    Statements

    ZEB1-associated drug resistance in cancer cells is reversed by the class I HDAC inhibitor mocetinostat (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit